The commercial problem
A supplier could look right and still fail commercially.
A credible product or manufacturing capability did not establish private-label availability, minimum order quantity, repeatable capacity, lead time, sample consistency, packaging capability, export readiness or landed cost.
Those questions needed to be answered before a supplier moved from discovery into product development or purchasing. The process therefore needed distinct gates for discovery, qualification, sampling and buying.
What we did
Kickoff built an international discovery universe of 239 potential makers and suppliers. That universe was treated as an input, not as an approved supply base.
For active product categories, the work then moved into direct supplier qualification. Qualification covered material and product specification, in-house manufacturing versus resale, private-label and custom capability, MOQ by SKU or design, production capacity, lead time, sampling, retail and export packaging, export readiness and the inputs required to calculate landed economics.
Selected routes progressed into supplier meetings, structured RFQs, MOQ discussions and sample requirements. Commercial viability was tested separately from product and aesthetic fit.
At one stage, confirmation of the applicable tariff treatment materially changed the landed economics of a promising route. The route was held rather than advanced using assumptions that no longer supported the buying case.
The result
The programme moved from a broad sourcing universe into a smaller set of active product-development routes with defined quotation requirements, sample dependencies, commercial gates and next decisions.
Several routes progressed into direct supplier discussions, structured RFQs and private-label qualification. Others remained in discovery or were held until the economics or evidence justified moving further.
The result was a controlled buying process in which suppliers and products could be moved forward, redesigned, held or rejected against explicit evidence.
Client identity and commercially identifying details are withheld. The page reports only outcomes and work that can be supported without exposing confidential counterparties, contract terms or unverified revenue.